Trade Almirall, S.A. - ALM CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.022099% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | -0.000123% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | Spain | ||||||||
| Commission on trade | 0% |
| Prev. Close | 8.33 |
| Open | 8.35 |
| 1-Year Change | -9.44% |
| Day's Range | 8.3 - 8.35 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 23, 2024 | 8.33 | 0.13 | 1.59% | 8.20 | 8.35 | 8.20 |
| Apr 22, 2024 | 8.21 | -0.04 | -0.48% | 8.25 | 8.32 | 8.21 |
| Apr 19, 2024 | 8.20 | 0.08 | 0.99% | 8.12 | 8.20 | 8.08 |
| Apr 18, 2024 | 8.16 | 0.17 | 2.13% | 7.99 | 8.17 | 7.99 |
| Apr 17, 2024 | 8.08 | 0.02 | 0.25% | 8.06 | 8.11 | 7.94 |
| Apr 16, 2024 | 8.10 | -0.02 | -0.25% | 8.12 | 8.14 | 8.04 |
| Apr 15, 2024 | 8.17 | 0.00 | 0.00% | 8.17 | 8.21 | 8.07 |
| Apr 12, 2024 | 8.26 | 0.06 | 0.73% | 8.20 | 8.32 | 8.19 |
| Apr 11, 2024 | 8.22 | 0.13 | 1.61% | 8.09 | 8.25 | 8.06 |
| Apr 10, 2024 | 8.14 | -0.03 | -0.37% | 8.17 | 8.26 | 8.09 |
| Apr 9, 2024 | 8.18 | 0.10 | 1.24% | 8.08 | 8.24 | 8.08 |
| Apr 8, 2024 | 8.19 | 0.10 | 1.24% | 8.09 | 8.20 | 8.05 |
| Apr 5, 2024 | 8.15 | 0.01 | 0.12% | 8.14 | 8.19 | 8.06 |
| Apr 4, 2024 | 8.22 | 0.14 | 1.73% | 8.08 | 8.23 | 8.03 |
| Apr 3, 2024 | 8.15 | 0.06 | 0.74% | 8.09 | 8.16 | 7.99 |
| Apr 2, 2024 | 8.09 | -0.12 | -1.46% | 8.21 | 8.25 | 8.07 |
| Mar 28, 2024 | 8.27 | 0.07 | 0.85% | 8.20 | 8.28 | 8.02 |
| Mar 27, 2024 | 8.18 | 0.05 | 0.62% | 8.13 | 8.20 | 7.93 |
| Mar 26, 2024 | 8.12 | 0.15 | 1.88% | 7.97 | 8.16 | 7.94 |
| Mar 25, 2024 | 8.01 | 0.05 | 0.63% | 7.96 | 8.06 | 7.94 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Almirall Company profile
About Almirall SA
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Almirall SA revenues increased 2% to EUR827.2M. Net loss totaled EUR40.9M vs. income of EUR74.3M. Revenues reflect Own Network (Spain) segment increase of 11% to EUR593.5M, Corporate segment increase of 3% to EUR27.1M, Spain segment increase of 5% to EUR250.2M, Europe/Middle East segment increase of 3% to EUR406.9M, Other Unallocated segment increase of 3% to EUR27.1M.
Equity composition
changed name from Laboratorios Almirall SA 5/2012, Scrip Issue, 1 new share for every 36 shares held (Factor: 1.02778).5/2013, Scrip Issue, 1 new share for every 68 shares held (Factor: 1.01471).5/2019, Scrip Issue, 1 new share for every 74 shares held (Factor: 1.01351).
| Industry: | Pharmaceuticals (NEC) |
Ronda General Mitre, 151
BARCELONA
BARCELONA 08022
ES
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com